Leukemia Clinical Trials

A listing of Leukemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 580 clinical trials
DISCO Application for the Improvement of Financial Outcomes in Patients With Hematologic Cancer

This phase II trial studies how well the DIScussion of COst (DISCO) application (app) works in improving financial outcomes in patients with hematologic cancer. The DISCO app is an electronic, highly scalable and tailorable education and communication intervention that may help researchers learn more about improving how patients and oncologists …

myeloid leukemia
cancer
cancer treatment
hematologic malignancy
leukemia
  • 0 views
  • 15 Jun, 2022
  • 1 location
Goal Management Training for Adult Survivors of Childhood Leukemia and Non-Hodgkins Lymphoma With Neurocognitive Sequelae

group-based treatment program for 60 adult survivors of childhood leukemia, and non Hodgkins lymphoma, diagnosed between 1980 and 2017 at an age below 18, with attention and executive function deficits

  • 0 views
  • 20 Jun, 2022
  • 3 locations
Humanized CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia

relapsed/refractory CD19+ acute lymphoblastic leukemia patients.

lymphoid leukemia
oximetry
acute leukemia
  • 41 views
  • 06 Jun, 2022
  • 1 location
FT538 in Subjects With Advanced Hematologic Malignancies

This is a Phase I dose-finding study of FT538 as monotherapy in acute myeloid leukemia (AML) and in combination with monoclonal antibodies in multiple myeloma (MM). The study will consist of a

fludarabine
measurable disease
refractory acute myeloid leukemia (aml)
leukemia
  • 0 views
  • 06 Jun, 2022
  • 9 locations
Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation

This study seeks to examine treatment therapy that will reduced regimen-related toxicity and relapse while promoting rapid immune reconstitution with limited serious graft-versus-host-disease (GVHD) and also improve disease-free survival and quality of life. The investigators propose to evaluate the safety and efficacy of selective naive T-cell depleted (by TCRɑβ and …

cancer
leukemia
tacrolimus
filgrastim
transplant conditioning
  • 189 views
  • 15 Jun, 2022
  • 1 location
In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies

relapsed B cell leukemia or lymphoma after a blood SCT organ SCT or for patients who are at high risk for relapse of their B cell leukemia or lymphoma.

oximetry
cancer
chemotherapy regimen
hodgkin's disease
lymphoma
  • 41 views
  • 21 Apr, 2022
  • 1 location
Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab

This is a single arm, open-label, Phase 1b study of pembrolizumab for patients with myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL) whose

myeloid leukemia
cancer
lymphoid leukemia
leukemia
bone marrow procedure
  • 11 views
  • 23 Apr, 2022
  • 1 location
CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies

Background B-cell leukemias and lymphomas are cancers that are often difficult to treat. The primary objective of this study is to determine the ability to take a

cytopenia
oximetry
cancer
gene therapy
bone marrow biopsy
  • 42 views
  • 28 Jun, 2022
  • 1 location
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia

This phase II trial studies how well liposome-encapsulated daunorubicin-cytarabine and venetoclax work in treating participants with acute myeloid leukemia that has come back (relapsed), does

  • 3 views
  • 06 Jun, 2022
  • 1 location
Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT

This study investigates the infusion safety and potential curative properties of ex-vivo expanded γδ T cells obtained from the same donor for patients who have hematological malignancies and have accepted allogeneic hematopoietic stem cell transplantation.

cell transplantation
acute leukemia
leukemia
ejection fraction
  • 0 views
  • 13 Apr, 2022
  • 1 location